Efficacy of Epimedii Folium and related preparations in experimental osteoporosis: a systematic review and meta-analysis
- 1Department of Orthopedics, Ziyang Hospital of Sichuan Provincial People’s Hospital Medical Group
- 2The Clinical Medical College, Chengdu University of Traditional Chinese Medicine
Abstract
Background: Epimedii Folium and related extracts have shown osteogenic, antiresorptive, antioxidant, and anti-inflammatory activities in experimental studies. This systematic review and meta-analysis evaluated their efficacy in rodent models of osteoporosis.
Methods: PubMed, Embase, Web of Science, China National Knowledge Infrastructure, and Wanfang Data were searched from their inception to 13 June 2026. Controlled in vivo studies using rat or mouse models of osteoporosis or experimentally induced bone loss were eligible. Random-effects models generated Hedges’ standardized mean differences (SMDs) with 95% confidence intervals (CIs). The risk of bias was assessed using the SYRCLE tool. The protocol was registered in PROSPERO (CRD420261428223). Sensitivity analyses examined heterogeneity, the influence of the Qi 2019 estimate, and the effects of multi-arm dependence, preparation type, disease model, duration, and dose. Certainty was appraised using an adaptation of GRADE for preclinical animal evidence.
Results: Twenty-nine independent rodent studies were included. Femoral BMD increased (20 comparisons from 9 studies; SMD = 1.66, 95% CI: 1.07–2.25; 95% prediction interval [PI]: −0.61 to 3.93; I ² = 73.77%). Excluding Qi 2019 reduced the SMD to 1.44 (95% CI: 0.96–1.92), while a three-level study-cluster robust model yielded an SMD of 2.25 (95% CI: 0.40–4.10). The average effects favored several regional BMD, microarchitectural, and biomechanical outcomes, but the majority of PIs crossed the null. PINP was not significant. The Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) assessment found that the majority of judgments were unclear, with nine domain-level judgments rated as high risk; certainty was very low.
Conclusion: Random-effects pooled estimates favored the examined oral Epimedii Folium-derived preparations for several regional BMD, trabecular microarchitecture, and ex vivo biomechanical outcomes in rodent models. However, wide prediction intervals, chemical and model heterogeneity, small study sizes, incomplete reporting, and correlated multi-arm comparisons limit confidence in the pooled effect magnitudes. Chemically standardized preparations and exposure-informed dosing are needed before clinical translation.
Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261428223 , identifier CRD420261428223.
Related
- The efficacy and safety of combining different commercial Chinese polyherbal preparations with conventional Western drugs in the treatment of diabetic osteoporosis: a network meta-analysis
- Efficacy and safety of selected Chinese herbal medicine preparations in treating carotid atherosclerosis: a systematic review and meta-analyses
- Efficacy and safety of commercial Chinese polyherbal preparations combined with biomedicine for elderly patients with primary insomnia: a systematic review and meta-analysis of randomized controlled trials
- Clinical Evidence of Orally Administered Herbal Preparations for Supportive Cancer Care: A PRISMA Systematic Review of Randomized Clinical Trials (1990–2026)
- Berberine and Berberine-Containing Alkaloid Preparations in Preclinical Models of Endometriosis and Adenomyosis: A Systematic Review
BibTeX
@article{wang2026efficacy,
title = {{Efficacy of Epimedii Folium and related preparations in experimental osteoporosis: a systematic review and meta-analysis}},
author = {Zuowen Wang and Ningchuan Zhang and Junxiao Ren and Chun Li},
journal = {Frontiers in Pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1951582},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1951582/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Efficacy of Epimedii Folium and related preparations in experimental osteoporosis: a systematic review and meta-analysis
AU - Zuowen Wang
AU - Ningchuan Zhang
AU - Junxiao Ren
AU - Chun Li
PY - 2026
DA - 2026/10/14
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1951582
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1951582/full
AB - Background: Epimedii Folium and related extracts have shown osteogenic, antiresorptive, antioxidant, and anti-inflammatory activities in experimental studies. This systematic review and meta-analysis evaluated their efficacy in rodent models of osteoporosis. Methods: PubMed, Embase, Web of Science, China National Knowledge Infrastructure, and Wanfang Data were searched from their inception to 13 June 2026. Controlled in vivo studies using rat or mouse models of osteoporosis or experimentally induced bone loss were eligible. Random-effects models generated Hedges’ standardized mean differences (SMDs) with 95% confidence intervals (CIs). The risk of bias was assessed using the SYRCLE tool. The protocol was registered in PROSPERO (CRD420261428223). Sensitivity analyses examined heterogeneity, the influence of the Qi 2019 estimate, and the effects of multi-arm dependence, preparation type, disease model, duration, and dose. Certainty was appraised using an adaptation of GRADE for preclinical animal evidence. Results: Twenty-nine independent rodent studies were included. Femoral BMD increased (20 comparisons from 9 studies; SMD = 1.66, 95% CI: 1.07–2.25; 95% prediction interval [PI]: −0.61 to 3.93; I ² = 73.77%). Excluding Qi 2019 reduced the SMD to 1.44 (95% CI: 0.96–1.92), while a three-level study-cluster robust model yielded an SMD of 2.25 (95% CI: 0.40–4.10). The average effects favored several regional BMD, microarchitectural, and biomechanical outcomes, but the majority of PIs crossed the null. PINP was not significant. The Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) assessment found that the majority of judgments were unclear, with nine domain-level judgments rated as high risk; certainty was very low. Conclusion: Random-effects pooled estimates favored the examined oral Epimedii Folium-derived preparations for several regional BMD, trabecular microarchitecture, and ex vivo biomechanical outcomes in rodent models. However, wide prediction intervals, chemical and model heterogeneity, small study sizes, incomplete reporting, and correlated multi-arm comparisons limit confidence in the pooled effect magnitudes. Chemically standardized preparations and exposure-informed dosing are needed before clinical translation. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261428223 , identifier CRD420261428223.
SN - 1663-9812
ER -